| - GRCh37:
- Chr4:995625
- GRCh38:
- Chr4:1001837
| IDUA | E119fs, E251fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:996229
- GRCh38:
- Chr4:1002441
| IDUA | L250*, L382* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:997250
- GRCh38:
- Chr4:1003462
| IDUA | Q418fs, Q550fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995537
- GRCh38:
- Chr4:1001749
| IDUA | G222fs, G90fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:994454
- GRCh38:
- Chr4:1000666
| IDUA | D119fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:980895
- GRCh38:
- Chr4:987107
| IDUA, SLC26A1 | A9fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995282
- GRCh38:
- Chr4:1001494
| IDUA | K174*, K42* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:996202-996214
- GRCh38:
- Chr4:1002414-1002426
| IDUA | N241fs, N373fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Nov 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:981694
- GRCh38:
- Chr4:987906
| IDUA, SLC26A1 | K86* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995494
- GRCh38:
- Chr4:1001706
| IDUA | S206*, S74* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995624-995625
- GRCh38:
- Chr4:1001836-1001837
| IDUA | E119fs, E251fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:996098-996099
- GRCh38:
- Chr4:1002310-1002311
| IDUA | | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:997156
- GRCh38:
- Chr4:1003368
| IDUA | L386fs, L518fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:980914-980915
- GRCh38:
- Chr4:987126-987127
| IDUA, SLC26A1 | A15fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:994735-994736
- GRCh38:
- Chr4:1000947-1000948
| IDUA | E151fs, E19fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995552-995554
- GRCh38:
- Chr4:1001764-1001766
| IDUA | T227fs, T95fs | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:980962
- GRCh38:
- Chr4:987174
| IDUA, SLC26A1 | H30Q | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S | Uncertain significance (Aug 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:980984
- GRCh38:
- Chr4:987196
| IDUA, SLC26A1 | R38C | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995477
- GRCh38:
- Chr4:1001689
| IDUA | N68K, N200K | Mucopolysaccharidosis type 1, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S | Uncertain significance (Mar 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994440
- GRCh38:
- Chr4:1000652
| IDUA | L114M | Mucopolysaccharidosis type 1, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S | Uncertain significance (Jun 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996733
- GRCh38:
- Chr4:1002945
| IDUA | | not provided, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S
| Pathogenic (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:985727
- GRCh38:
- Chr4:991939
| IDUA, SLC26A1 | | not provided, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis, MPS-I-H/S | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:997485
- GRCh38:
- Chr4:1003697
| IDUA | | not provided, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995888
- GRCh38:
- Chr4:1002100
| IDUA | V172fs, V304fs | Mucopolysaccharidosis type 1 | Pathogenic (Sep 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995483
- GRCh38:
- Chr4:1001695
| IDUA | Y202*, Y70* | Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis type 1 | Pathogenic/Likely pathogenic (Feb 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995301
- GRCh38:
- Chr4:1001513
| IDUA | W180*, W48* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Dec 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995287
- GRCh38:
- Chr4:1001499
| IDUA | W175*, W43* | Hurler syndrome, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S
| Pathogenic/Likely pathogenic (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994723
- GRCh38:
- Chr4:1000935
| IDUA | Q147*, Q15* | Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis type 1 | Pathogenic/Likely pathogenic (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996882
- GRCh38:
- Chr4:1003094
| IDUA | W355*, W487* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Mar 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr4:996549
- GRCh38:
- Chr4:1002761
| IDUA | Q275*, Q407* | Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (Sep 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr4:995256
- GRCh38:
- Chr4:1001468
| IDUA | G165D, G33D | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995660
- GRCh38:
- Chr4:1001872
| IDUA | H262fs, H130fs | Hurler syndrome, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis type 1, not provided
| Pathogenic (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995596
- GRCh38:
- Chr4:1001808
| IDUA | H108R, H240R | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S | Pathogenic/Likely pathogenic (Apr 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:983772
- GRCh38:
- Chr4:989984
| IDUA, SLC26A1 | V319M | Mucopolysaccharidosis, MPS-I-H/S | Benign (Sep 27, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr4:998096
- GRCh38:
- Chr4:1004308
| IDUA | W494*, W626* | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Pathogenic (Jun 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996600
- GRCh38:
- Chr4:1002812
| IDUA | A292T, A424T | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Uncertain significance (Jan 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994681-994686
- GRCh38:
- Chr4:1000893-1000898
| IDUA | | Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis type 1, Hurler syndrome | Pathogenic/Likely pathogenic (Feb 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996599
- GRCh38:
- Chr4:1002811
| IDUA | S423R, S291R | not provided, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Pathogenic/Likely pathogenic (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995492
- GRCh38:
- Chr4:1001704
| IDUA | C205*, C73* | not provided, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S
| Pathogenic/Likely pathogenic (Oct 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996899
- GRCh38:
- Chr4:1003111
| IDUA | P361R, P493R | not provided, Inborn genetic diseases, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis type 1
| Uncertain significance (Nov 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:981703
- GRCh38:
- Chr4:987915
| SLC26A1, IDUA | R89W | Mucopolysaccharidosis type 1, not provided, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Pathogenic/Likely pathogenic (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:997185
- GRCh38:
- Chr4:1003397
| IDUA | L526P, L394P | not provided, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S
| Conflicting interpretations of pathogenicity (Jul 17, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr4:996518
- GRCh38:
- Chr4:1002730
| IDUA | | Hurler syndrome, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Likely pathogenic (May 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:998117
- GRCh38:
- Chr4:1004329
| IDUA | S633L, S501L | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome | Pathogenic (Sep 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:997799
- GRCh38:
- Chr4:1004011
| IDUA | | not provided, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S
| Pathogenic/Likely pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:981028
- GRCh38:
- Chr4:987240
| SLC26A1, IDUA | F52L | Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome | Uncertain significance (Mar 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994397
- GRCh38:
- Chr4:1000609
| IDUA | | Hurler syndrome, Mucopolysaccharidosis type 1 | Conflicting interpretations of pathogenicity (Sep 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr4:998080
- GRCh38:
- Chr4:1004292
| IDUA | R621G, R489G | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, not provided | Uncertain significance (Jan 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:980802
- GRCh38:
- Chr4:987014
| IDUA, SLC26A1 | | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S | Uncertain significance (Aug 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996012
- GRCh38:
- Chr4:1002224
| IDUA | | not provided, Mucopolysaccharidosis, MPS-I-H/S, not specified, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995997
- GRCh38:
- Chr4:1002209
| IDUA | | not provided, Mucopolysaccharidosis, MPS-I-H/S, not specified, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995422
- GRCh38:
- Chr4:1001634
| IDUA | | not provided, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, not specified, Hurler syndrome | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:997095
- GRCh38:
- Chr4:1003307
| IDUA | | not specified, Mucopolysaccharidosis, MPS-I-H/S, not provided
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996768
- GRCh38:
- Chr4:1002980
| IDUA | | not specified, Mucopolysaccharidosis, MPS-I-H/S, not provided, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995530
- GRCh38:
- Chr4:1001742
| IDUA | L218P, L86P | Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, not provided, Hurler syndrome, Mucopolysaccharidosis type 1
| Pathogenic (May 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994668
- GRCh38:
- Chr4:1000880
| IDUA | | not provided, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome | Pathogenic (Jan 26, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:981024
- GRCh38:
- Chr4:987236
| IDUA, SLC26A1 | G51D | Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis type 1, not provided, Hurler syndrome
| Pathogenic (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:997222
- GRCh38:
- Chr4:1003434
| IDUA | H539fs, H407fs | Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, not provided, Hurler syndrome
| Pathogenic (Sep 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:980971
- GRCh38:
- Chr4:987183
| IDUA, SLC26A1 | H33Q | Mucopolysaccharidosis type 1, not specified, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, not provided, Mucopolysaccharidosis, MPS-I-S
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995919
- GRCh38:
- Chr4:1002131
| IDUA | | Mucopolysaccharidosis type 1, Hurler syndrome, not provided, not specified, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995868
- GRCh38:
- Chr4:1002080
| IDUA | | Mucopolysaccharidosis type 1, Inborn genetic diseases, not specified, not provided, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome | Benign/Likely benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995459
- GRCh38:
- Chr4:1001671
| IDUA | | Mucopolysaccharidosis type 1, not specified, not provided, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:995305
- GRCh38:
- Chr4:1001517
| IDUA | | Mucopolysaccharidosis type 1, Hurler syndrome, not specified, not provided, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994452
- GRCh38:
- Chr4:1000664
| IDUA | | Mucopolysaccharidosis type 1, Hurler syndrome, not specified, not provided, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis, MPS-I-H/S
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:994414
- GRCh38:
- Chr4:1000626
| IDUA | R105Q | Mucopolysaccharidosis type 1, not specified, not provided, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S
| Benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996690
- GRCh38:
- Chr4:1002902
| IDUA | V454I, V322I | not specified, Mucopolysaccharidosis type 1, Mucopolysaccharidosis, MPS-I-H/S, Hurler syndrome, not provided, Mucopolysaccharidosis, MPS-I-S
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996121
- GRCh38:
- Chr4:1002333
| IDUA | L346R, L214R | Hurler syndrome, Mucopolysaccharidosis type 1 | Pathogenic (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996175
- GRCh38:
- Chr4:1002387
| IDUA | T364M, T232M | Mucopolysaccharidosis type 1 | Pathogenic (Jul 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:998074
- GRCh38:
- Chr4:1004286
| IDUA | R619G, R487G | Hurler syndrome | Uncertain significance (Apr 25, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr4:981704
- GRCh38:
- Chr4:987916
| IDUA, SLC26A1 | R89Q | Mucopolysaccharidosis type 1 | Pathogenic (Jun 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:998179
- GRCh38:
- Chr4:1004391
| IDUA | | Mucopolysaccharidosis type 1 | Pathogenic (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:996890
- GRCh38:
- Chr4:1003102
| IDUA | L490P, L358P | Mucopolysaccharidosis type 1, not provided, Hurler syndrome
| Pathogenic/Likely pathogenic (Aug 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:998080
- GRCh38:
- Chr4:1004292
| IDUA | R621*, R489* | Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis type 1, not provided, Hurler syndrome
| Pathogenic (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:997206
- GRCh38:
- Chr4:1003418
| IDUA | P533R, P401R | Mucopolysaccharidosis type 1, Inborn genetic diseases, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, not provided, Hurler syndrome | Pathogenic (Jan 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:981646
- GRCh38:
- Chr4:987858
| IDUA, SLC26A1 | Q70* | IDUA-related condition, Mucopolysaccharidosis type 1, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, not provided, Hurler syndrome, Mucopolysaccharidosis, MPS-I-S, Mucopolysaccharidosis, MPS-I-H/S, Interstitial pneumonitis | Pathogenic (Feb 13, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:996535
- GRCh38:
- Chr4:1002747
| IDUA | W402*, W270* | IDUA-related condition, Inborn genetic diseases, Mucopolysaccharidosis type 1, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysaccharidosis, MPS-I-S, not provided, Hurler syndrome, Mucopolysaccharidosis, MPS-I-H/S, Mucopolysacchariduria, See cases ...see more | Conflicting interpretations of pathogenicity (Sep 27, 2023) | criteria provided, conflicting interpretations |